Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Sulfurous Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurous Acid SCHEMBL9436266 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL27391564 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL1093823 | 1.00 | CA1 (0.75) | CA1CA2 | |
| Sulfurous Acid SCHEMBL3884261 | 1.00 | CA1 (0.75) | CA1CA2 | |
| Sulfurous Acid SCHEMBL3186682 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL3771285 | 1.00 | CA1 (0.75) | CA1CA2 | |
| Sulfurous Acid SCHEMBL8003764 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL28048784 | 1.00 | CA1 (0.75) | CA1CA2 | |
| Sulfurous Acid SCHEMBL23249641 | 0.94 | CA1 (0.67) | CA1CA2 | |
| Sulfurous Acid SCHEMBL28396462 | 0.94 | CA1 (0.67) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11926545-B2 | Catalytic hydrogel membrane reactor for treatment of aqueous contaminants | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2024-03-12 | — | — | US | disclosed |
| US-20210230028-A1 | CATALYTIC HYDROGEL MEMBRANE REACTOR FOR TREATMENT OF AQUEOUS CONTAMINANTS | UNIV NOTRE DAME DU LAC (US) | 2021-07-29 | — | — | US | disclosed |
| US-9708340-B2 | Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-20160185795-A1 | UREA DERIVATIVES AND THEIR USE AS FATTY-ACID BINDING PROTEIN (FABP) INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2016-06-30 | — | — | US | disclosed |
| CN-103080240-B | Solid solution pigment nanoparticles and method for producing solid solution pigment nanoparticles with controlled solid solution ratio | M. TECHNIQUE Co.,Ltd. (JP) | 2016-04-13 | — | — | CN | disclosed |
| CN-103145730-B | Two thieno-fluorenes and derivative and preparation method | EAST CHINA NORMAL UNIVERSITY (CN) | 2016-02-03 | — | — | CN | disclosed |
| CN-105246876-A | Condensed heterocyclic compound and pest control use thereof | SUMITOMO CHEMICAL CO | 2016-01-13 | — | — | CN | disclosed |
| CN-105143229-A | Substituted xanthines and methods of use thereof | HYDRA BIOSCIENCES INC | 2015-12-09 | — | — | CN | disclosed |
| CN-104968663-A | Fused heterocyclic compound | SUMITOMO CHEMICAL CO | 2015-10-07 | — | — | CN | disclosed |
| CN-102666548-B | Tricyclic antibiotics | BASILEA PHARMACEUTICA AG | 2015-07-15 | — | — | CN | disclosed |
| CN-1220266-A | Intermediates of protein kinase C inhibitors and preparation process thereof | LILLY CO ELI (US) | 1999-06-23 | — | — | CN | disclosed |
| CN-1035876-C | Tetrahydrothiophene derivatives | SANTEN PHARMACEUTICAL CO LTD (JP) | 1997-09-17 | — | — | CN | disclosed |
| CN-1137794-A | 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists | PROCTER & GAMBLE (US) | 1996-12-11 | — | — | CN | disclosed |
| CN-1111247-A | Protein kinase C inhibitors | LILLY CO ELI (US) | 1995-11-08 | — | — | CN | disclosed |
| WO-1995019185-A1 | FUNCTIONALIZED AZA-MACROBICYCLIC LIGANDS FOR IMAGING APPLICATIONS | MALLINCKRODT MEDICAL, INC. (US) | 1995-07-20 | — | — | WO | disclosed |
| CN-1087338-A | Therapeutical agent | BOOTS CO PLC (GB) | 1994-06-01 | — | — | CN | disclosed |
| US-5294375-A | Thermochromic materials | POLAROID CORPORATION (US) | 1994-03-15 | — | — | US | disclosed |
| CN-1079739-A | Tetrahydrothiophene derivatives | SANTEN PHARMACEUTICAL CO LTD (JP) | 1993-12-22 | — | — | CN | disclosed |
| CN-1022691-C | Composition of free redical polymerization | SHOWA DENKO KK (JP) | 1993-11-10 | — | — | CN | disclosed |
| CN-1047515-A | The composition of free redical polymerization | SHOWA DENKO KK (JP) | 1990-12-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185795-A1 | UREA DERIVATIVES AND THEIR USE AS FATTY-ACID BINDING PROTEIN (FABP) INHIBITORS | FABP1, FABP5, FABP2 | CA1 4491/4885CA2 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.